Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: gg cox who wrote (11963)	1/24/2003 1:30:47 AM
From: russet	Read Replies (2) \| Respond to of 14101

Hello gg, There are stocks you can milk, time and time again,...they react predictably to news and lack of news. Some threads give the temperature of the fervor of the stock buyers and investors, especially when they come with a dedicated cult following, like this one. As far as gloating,...yes a bit, but it suits the tenor of replies some of this threads participants commonly use to remarks that go counter to their beliefs, assumptions, and logic. The thread header sets the premise and tenor of the thread as it emphatically calls anyone who disagrees with the threads chief proponents, part of the "sea of stupidity", illogical thinkers, drivel makers etc. You might have read this if you monitor the Stockhouse threads,...it bears repeating,... http://www.stockhouse.ca/bullboards/viewmessage.asp?no=5952840&tableid=0 Posted By: Beckysboss Post Time: 1/23/03 09:20 I haven't been in DMX for some time now, but I follow it out of a sense of attachment, a seemingly good prospect that in the end I decided just wasn't going to pan out. I wish nothing but success to those who are with it still, and hope it proves me - and you - wrong. WUWT seems to me this works both ways , I'm sure the longs like Jkay would prefer to dominate this BB with their pictures of predicted phenomenal success of this product and this company. Much easier as a shareholder to accept these glowing accounts of $20 by June 2002 or Stockietalkies $50 by 2001 , which is exactly what they told folks could be expected based on some sort of probabilities. Then you have the likes of Wolf producing revenue estimates predicting vast sums of wealth spun off where there is little. Those to be produced by a product that is far from unique with short patent life. MBartlett suggested WF10 was perhaps the next cure for Aids many times over, a staunch Rebecca supporter regardless of the issues. They hype the company, others join in providing drop dead dates for FDA, J&J that come and go, you watch the price of the stock and you know people are buying based on this crap. That's very sad. WF10 as product can't even get out of the gate in areas it is already on the market, look at the revenue it produces. Thailand with some of the highest Aids rates in the world doesn't use it as the magic bullet because they tell us its to expensive for them, ok sure right. Mixing up sodium chlorite and hydrogen peroxide that can be sold as cheapo wound healing agent in the form of Oxoferin couldn't be used as a injectable just as cheaply when its called WF10? People searching the world over for a cure ignore the obvious? Fact is many have been around this company for a long time and watched it spiral down , mgmt. produce glowing accounts of future prospects , supported by these good guys on the BB's and then do nothing but stub their toes in the market and with regulators. Some balance is needed to these folks that build expectations that are far from reality. The name calling by the supporters of DMX is a evident as by the bashers, just read a few of Jkays knee jerk posts. This is a company on its knees, unable to secure financing through the normal routes because of the lack of prospective revenues. Many of us saw this coming long ago and said so. Perhaps FDA will come by and save it, perhaps not, clinical trials are hidden from view most times, it is hard to get a true picture of where the regulator actually stands, success is "always" around the next corner. This is a biotech that is far riskier than most out there, no cash, limited revenue prospects and a CEO that seems best at managing her own portfolio than managing a biotech. Might as well flip a coin with your investment dollars. I don't wish for failure here, but I do recognize the path this company has been on for a long time , some would prefer to detach themselves from that thinking, sorry I see that as my job as an investor, separating emotion and fact. Reality is the so called good guy posters have done more damage to investors than any so called basher on this BB, balance is needed , too bad cognitive dissonance works the way it does.